会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method and apparatus for two-channel recording of video signals
    • 用于视频信号双通道录像的方法和装置
    • US5394276A
    • 1995-02-28
    • US49589
    • 1993-04-20
    • Makoto Adachi
    • Makoto Adachi
    • H04N5/92H04N7/015H04N9/797H04N9/81H04N5/78
    • H04N9/7973Y10S348/91
    • A video signal recording apparatus is provided with first and second channels for transmitting an input video signal. The first channel has a line memory for conducting a 1H delay on data and a time-base-extension line memory for conducting time base extension on the data with the 1H delay. The data subjected to the time base extension undergoes D/A conversion to be an output of the first channel. On the other hand, the second channel does not have a line memory for a 1H delay, and the video signal without delay is subjected to time base extension and undergoes D/A conversion to be an output of the second channel. In the arrangement, odd lines and even lines respectively contained in adjoining two frames in each channel are reversed such that in a certain frame, odd lines of the input video signal are transmitted through the first channel with even lines through the second channel. In the next frame, even lines are transmitted through the first channel with odd lines through the second channel. Thus, influences on the reproduced picture due to the difference of circuit characteristics is averaged and the perception to unevenness of color or brightness is avoided.
    • 视频信号记录装置具有用于发送输入视频信号的第一和第二信道。 第一通道具有用于在数据上进行1H延迟的行存储器和用于对1H延迟的数据进行时基扩展的时基扩展线存储器。 经过时基扩展的数据经历D / A转换为第一通道的输出。 另一方面,第二通道不具有用于1H延迟的行存储器,并且没有延迟的视频信号经受时基扩展,并且经历D / A转换为第二通道的输出。 在这种布置中,分别包含在每个通道中的相邻两个帧中的奇数行和偶数行被反转,使得在某个帧中,输入视频信号的奇数行通过第二通道的偶数行通过第一通道传输。 在下一帧中,偶数行通过第二通道以奇数行通过第一通道传输。 因此,由于电路特性的差异对对再现图像的影响被平均,并且避免了对颜色或亮度的不均匀性的感知。
    • 9. 发明授权
    • Tricyclic compounds having sPLA2-inhibitory activities
    • 具有sPLA2抑制活性的三环化合物
    • US06703385B1
    • 2004-03-09
    • US10031443
    • 2002-01-22
    • Mitsuaki OhtaniMasahiro FujiMakoto AdachiTomoyuki Ogawa
    • Mitsuaki OhtaniMasahiro FujiMakoto AdachiTomoyuki Ogawa
    • A61K3133
    • C07D471/04
    • The present invention provides a compound having sPLA2 inhibiting activity. The compound represented by the formula (I): wherein R1 is (a) C1 to C20 alkyl, C2 to C20 alkenyl, C2 to C20 alkynyl, carbocyclic groups, heterocyclic groups or the like; R2 is COCONH2 or the like; Q1 is a nitrogen atom or C—R4; one of R3 and R4 is —(L2)-(acidic group) wherein L2 is a group connecting with an acid group and the length of the connecting groups 1 to 5 atoms, and the other is a hydrogen atom; R21 and R22 are hydrogen atoms or the like; X is —CR23R24— or the like wherein R23 and R24 are hydrogen atoms or the like; Y is —CR25R26— or the like wherein R25 and R26 are hydrogen atoms or the like; Z is CH2 or the like; a broken line ( - - - ) represents the presence or absence of a bond, its prodrug, their pharmaceutically acceptable salt, or solvate thereof.
    • 本发明提供具有sPLA2抑制活性的化合物。式(I)表示的化合物:其中R 1为(a)C 1至C 20烷基,C 2至C 20烯基,C 2至C 20炔基,碳环基,杂环基 或类似物; R 2是COCONH 2等; Q 1是氮原子或C-R 4; R 3和R 4之一是 - (L 2) - (酸性基团)其中L 2是与酸基连接的基团和连接基团的长度为1至5个原子,以及 另一个是氢原子; R 21和R 22是氢原子等; X是-CR 23 R 24 - 等,其中R 23和R 24是氢原子等; Y是-CR 25 R 26 - 等,其中R 25和R 26是氢原子等; Z是CH 2等; 虚线( - - - )表示键的存在或不存在,其前体药物,其药学上可接受的盐或溶剂合物。
    • 10. 发明授权
    • Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
    • 具有sPLA2抑制作用的吡咯并[1,2-b]哒嗪衍生物
    • US06472389B1
    • 2002-10-29
    • US09673413
    • 2000-10-18
    • Mitsuaki OhtaniMasahiro FujiYoshikazu FukuiMakoto Adachi
    • Mitsuaki OhtaniMasahiro FujiYoshikazu FukuiMakoto Adachi
    • A61K315025
    • C07D487/04
    • The present invention provides a compound having sPLA2 inhibiting activity. The compound represented by the formula (I): wherein R1 is —(L1)—R6 wherein L1 is a divalent linking group of 1 to 18 atoms or the like, and R6 is a carbocyclic ring substituted by at least one non-interfering substituent or the like; R2 is C1 to C3 alkyl or the like; R3 is —(L2)-(acidic group); R4 and R5 are hydrogen atoms, non-interfering substituents, carbocyclic groups or the like; X is independently oxygen atom of sulfur atom; and RA is —C(═X)—C(═X)—NH2 or the like; the prodrugs thereof, their pharmaceutically acceptable salts, or their solvates, and a composition for inhibiting sPLA2 containing them as effective ingredients.
    • 本发明提供具有sPLA2抑制活性的化合物。式(I)表示的化合物:其中R1为 - (L1)-R6,其中L1为1至18个原子的二价连接基团等,R6为 被至少一个非干扰取代基等取代的碳环; R2是C1-C3烷基等; R3是 - (L2) - (酸性基团); R4和R5是氢原子,非干扰取代基,碳环基团等; X独立地是硫原子的氧原子; RA为-C(= X)-C(= X)-NH 2等; 其前体药物,其药学上可接受的盐或其溶剂合物,以及用于抑制含有它们作为有效成分的sPLA2的组合物。